Five Stocks Under $10 to Watch for Q2 2025 Growth
Stocks priced under $10 are attracting investors seeking to diversify their portfolios without a large initial investment. These lower-cost equities provide opportunities to purchase more shares, which can lead to significant percentage gains.
We have identified five companies, currently trading below $10, that span a variety of sectors. These selections show promising growth potential as we head into the second quarter of 2025, giving investors a starting point for further research into potentially undervalued assets or those on the verge of notable expansion.
Ford Motor Company: Dividends and the Electric Future
[content-module:CompanyOverview|NYSE:F]
Ford Motor Company (NYSE: F) is embracing a transformative shift aimed at securing its place in the fast-changing electric vehicle market. While maintaining its longstanding internal combustion engine (ICE) vehicle segment, known as Ford Blue, the company is channeling substantial resources into electric vehicles (EVs) through its Model e division.
For the full year of 2024, Ford reported impressive financial results, achieving a record revenue of $185 billion. Additionally, it presented an optimistic outlook for 2025, reflecting its robust financial health. The company’s commitment to returning value to shareholders is evident with a dividend yield that currently exceeds 6%.
To drive its electric future, Ford has committed up to $50 billion in EV infrastructure investments by 2026, which includes the establishment of a new EV manufacturing campus. The company aims for annual sales of 2 million EVs by that target year.
Nokia: Strengthening the Telecom Future
[content-module:CompanyOverview|NYSE:NOK]
Nokia Oyj (NYSE: NOK), based in Finland, stands as a global leader in telecommunications infrastructure and plays a crucial role in deploying 5G networks as well as developing 6G technology. Operating across four distinct business groups, Nokia provides comprehensive network solutions for service providers, businesses, and governments globally.
Recent financial performance indicates a healthier outlook for Nokia. The company surpassed earnings expectations for Q4 2024 and has an optimistic forecast for 2025. It anticipates a Comparable Operating Profit of between approximately $2.1 billion and $2.7 billion, adjusted for currency conversion, accompanied by robust free cash flow conversion.
Nokia also engages in active capital returns through a share buyback program and plans for dividend increases. Its leadership position in telecommunications puts it in a prime position to benefit from the continued global rollout of 5G infrastructure, while its entry into high-growth markets like data center networking aids in diversifying its revenue sources.
Goodyear: A Tire Giant in Transition
[content-module:CompanyOverview|NASDAQ:GT]
The Goodyear Tire & Rubber Company (NASDAQ: GT) is in the midst of a transformation plan intended to enhance profitability and curb debt. With well-known brands such as Goodyear, Cooper Tires, and Dunlop, the company produces and sells tires for a variety of vehicles worldwide.
Goodyear’s Q4 2024 results exceeded market predictions, driven by early successes from its “Goodyear Forward” initiative, which aims to deliver $1.5 billion in annual cost savings and efficiency gains by 2025 through reduced costs and optimized operations.
The company recorded a full-year 2024 segment operating income of $1.318 billion, reflecting a significant $350 million increase year-over-year. The “Goodyear Forward” initiative is poised to further enhance margins and facilitate substantial debt reduction in the years ahead.
Standard Lithium: Pioneering Lithium Recovery
[content-module:CompanyOverview|NYSE:SLI]
Standard Lithium Ltd. (NYSE: SLI) offers a unique high-risk, high-reward investment opportunity within the EV battery supply chain. Utilizing innovative Direct Lithium Extraction (DLE) technology, the company aims to extract lithium from brine in a more efficient and environmentally friendly manner.
As lithium becomes increasingly essential for EV batteries, Standard Lithium’s focus on U.S. lithium resources positions it for substantial growth. The flagship projects in Arkansas’s Smackover Formation, known for its rich lithium brine deposits, have garnered interest. A notable accomplishment is the conditional $225 million grant received from the U.S. Department of Energy for the South West Arkansas Project, which enhances its production prospects.
Furthermore, a licensing agreement with Koch Technology Solutions for its Li-Pro LSS DLE technology further strengthens its operational capabilities.
Mereo BioPharma: Innovating for Rare Diseases
[content-module:CompanyOverview|NASDAQ:MREO]
Mereo BioPharma Group plc (NASDAQ: MREO) is a clinical-stage biopharmaceutical company offering a high-stakes investment option in the biotechnology realm. The company focuses on acquiring and developing therapies for rare and specialty conditions, targeting populations with unmet medical needs.
Mereo’s pipeline features candidates like Setrusumab for osteogenesis imperfecta (OI) and Alvelestat for alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD), both nearing critical late-stage development.
Recently, Setrusumab received Breakthrough Therapy Designation from the U.S. FDA, underscoring its potential for addressing significant unmet needs in OI treatment. Alvelestat is progressing toward Phase 3 readiness, and the company is exploring partnership opportunities. Mereo BioPharma has secured funding that extends its cash runway into 2027, providing necessary financial backing for ongoing clinical efforts.
Moving Forward: Research and Diversification
These five companies, all priced under $10, offer intriguing investment opportunities for Q2 2025.
Ford and Goodyear, with their long-standing industry status, present valuable assets with dividend prospects. Meanwhile, Nokia stands to gain from the expansion of 5G technology, while Standard Lithium and Mereo BioPharma offer higher-risk but potentially rewarding options in emerging fields.
When considering these stocks, investors should assess their risk appetite and investment strategies.
Before proceeding with your next trade, consider the recommendations of top analysts. MarketBeat monitors leading research analysts and the stocks they advocate daily.
Our team has compiled a list of five stocks that top analysts are quietly urging clients to buy before wider market recognition. Notably, none of these are large-cap stocks.
The views and opinions expressed herein are solely those of the author and do not necessarily reflect those of Nasdaq, Inc.
